Published
Update
Video length: 2 min
Health: what is lixisenatide, this antidiabetic drug which could stop the progression of Parkinson’s?
A drug from the same family as the antidiabetic Ozempic, which is a hit in the United States where it is sometimes misused, could stop the progression of Parkinson’s disease. Explanations, Thursday April 11 on the 8 p.m. set, by doctor and journalist Damien Mascret.
(France 2)
A drug from the same family as the antidiabetic Ozempic, which is a hit in the United States where it is sometimes misused, could stop the progression of Parkinson’s disease. Explanations, Thursday April 11 on the 8 p.m. set, by doctor and journalist Damien Mascret.
A drug from the same family as the Ozempic could stop the development of Parkinson’s disease. “It’s from the same family, but this one will even go as far as the brain”, explains on the set of 20 Heures the doctor and journalist Damien Mascret, who recalls that 271,000 people suffer from Parkinson’s disease in France, and that 26,000 fall ill each year. All suffer from the same lesion located in the heart of the brain, where the neurons responsible for producing dopamine are located.
A study to be extended
Neurons are “crucial, because dopamine helps regulate movements”, says the doctor. The lack of dopamine thus causes tremors, particularly of the hand and at rest, but also “walking problems” and slowing of movements. This antidiabetic drug, lixisenatide, would stop the progression of symptoms. Damien Mascret specifies, however, that the result will have to be confirmed by a study on more patients and over a longer period. If confirmed, it would be “the first drug to stop the progression of Parkinson’s disease”.
Among Our sources:
New England Journal of Medicine
Non-exhaustive list.
